Figure 5

TNB and immune infiltration associated with ERCC mutations were evaluated as follows: (A) TNB comparison between the ERCC-MT subgroup and ERCC-WT subgroup in the TCGA NSCLC and Melanoma cohort; (B) TNB comparison between the ERCC-MT subgroup and ERCC-WT subgroup in the TCGA NSCLC cohort; (C) TNB comparison between the ERCC-MT subgroup and ERCC-WT subgroup in the TCGA Melanoma cohort; (D) Comparison of the infiltration scores of 22 immune cell types between the ERCC-MT and ERCC-WT subgroups (*p < 0.05; **p < 0.01; ***p < 0.001).